Cargando…
Soluble ST2 and CD163 as Potential Biomarkers to Differentiate Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
The differentiation of primary hemophagocytic lymphohistiocytosis (pHLH) and macrophage activation syndrome (MAS) poses a challenge to hematologists. The aim of this study was (1) to compare the levels of soluble ST2 (sST2), sCD163, IFN-γ, IL-10, IL-18, TNF-α and Serum soluble interleukin-2 receptor...
Autores principales: | Gao, Zhuo, Wang, Yini, Wang, Jingshi, Zhang, Jia, Wang, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328040/ https://www.ncbi.nlm.nih.gov/pubmed/30671214 http://dx.doi.org/10.4084/MJHID.2019.008 |
Ejemplares similares
-
Primary hemophagocytic lymphohistiocytosis in adults: the utility of family surveys in a single-center study from China
por: Jin, Zhili, et al.
Publicado: (2018) -
Successful resolution of hemophagocytic lymphohistiocytosis during the chemotherapy course of acute myelocytic leukemia with ruxolitinib
por: Song, Yue, et al.
Publicado: (2022) -
Genotype characteristics and immunological indicator evaluation of 311 hemophagocytic lymphohistiocytosis cases in China
por: Zhang, Jia, et al.
Publicado: (2020) -
PEG-aspargase and DEP regimen combination therapy for refractory Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis
por: Wang, Jingshi, et al.
Publicado: (2016) -
HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center
por: Song, Yue, et al.
Publicado: (2020)